uterine fibroids
Women's health · 2016–2024
3decisions
2medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| linzagolix Treatment of symptomatic uterine fibroids in adult premenopausal women who are unsuitable for, or have had an inadequate response to prior hormonal therapies. | Jul 2024 | Not recommended | none received |
| ulipristal acetate Acute management of moderate to severe symptomatic uterine fibroids prior to planned surgery in patients eligible for and planning surgery. | Mar 2017 | Not recommended | none received |
| ulipristal acetate Management of moderate to severe symptoms of uterine fibroids prior to planned surgery. | Jul 2016 | Not recommended | input received |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 3 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.